Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Patti G, et al. Among authors: mangiacapra f. J Am Coll Cardiol. 2008 Sep 30;52(14):1128-33. doi: 10.1016/j.jacc.2008.06.038. J Am Coll Cardiol. 2008. PMID: 18804738 Free article. Clinical Trial.
Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Muller O, Hamilos M, Bartunek J, Ulrichts H, Mangiacapra F, Holz JB, Ntalianis A, Trana C, Dierickx K, Vercruysse K, De Bruyne B, Wijns W, Barbato E. Muller O, et al. Among authors: mangiacapra f. Am J Cardiol. 2010 Feb 1;105(3):333-8. doi: 10.1016/j.amjcard.2009.09.033. Epub 2009 Dec 22. Am J Cardiol. 2010. PMID: 20102944
High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
Mangiacapra F, De Bruyne B, Muller O, Trana C, Ntalianis A, Bartunek J, Heyndrickx G, Di Sciascio G, Wijns W, Barbato E. Mangiacapra F, et al. JACC Cardiovasc Interv. 2010 Jan;3(1):35-40. doi: 10.1016/j.jcin.2009.10.024. JACC Cardiovasc Interv. 2010. PMID: 20129566 Free article.
Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
Di Sciascio G, Patti G, Pasceri V, Colonna G, Mangiacapra F, Montinaro A; ARMYDA-4 RELOAD Investigators. Di Sciascio G, et al. Among authors: mangiacapra f. Eur Heart J. 2010 Jun;31(11):1337-43. doi: 10.1093/eurheartj/ehq081. Epub 2010 Apr 2. Eur Heart J. 2010. PMID: 20363764 Clinical Trial.
Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
Di Sciascio G, Patti G, Pasceri V, Gatto L, Colonna G, Montinaro A; ARMYDA-5 PRELOAD Investigators. Di Sciascio G, et al. J Am Coll Cardiol. 2010 Aug 10;56(7):550-7. doi: 10.1016/j.jacc.2010.01.067. J Am Coll Cardiol. 2010. PMID: 20688209 Free article. Clinical Trial.
141 results